Email ID : 
Password : 
Forgot Your Password ? 

Only Report Titles
Titles & Keywords
NOTE: Site best viewed with Internet Explorer
  GENE AMPLIFICATION TECHNOLOGIES
A Global Strategic Business Report

This report analyzes the worldwide markets for Gene Amplification Technologies in Millions of US$. The major product segments analyzed are Polymerase Chain Reaction, and Other Gene Amplification Technologies. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 93 companies including many key and niche players worldwide such as Abbott Laboratories, Applied Biosystems, Becton, Dickinson and Company, bioMerieux, Bio-Rad Laboratories, Cepheid, QIAGEN N.V, Roche Diagnostics, Rubicon Genomics, and Takara Bio, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

CODE:    MCP-1102  PAGES:    282
PRICE:    $3950  DATE:       October 2008
COMPANIES:  93  MARKET DATA TABLES:   62
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

 TABLE OF CONTENTS  
  GENE AMPLIFICATION TECHNOLOGIES (Complete Report) Pages : 282   | $3950
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS3$100
   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
Quantitative Techniques & Analytics.....I-2
  
   Product Definitions and Scope of Study.....I-3
Definitions.....I-3
Polymerase Chain Reaction.....I-3
Other Gene Amplification Technologies.....I-3
  
II. EXECUTIVE SUMMARY36$2250
  1. Industry Overview.....II-12 $200  
   PCR Dominates Amplification Technologies.....II-1
Miniaturization – The Next Big Focus.....II-1
Critical in Diagnostic Procedures.....II-1
1$100
   Leading Players.....II-2
1$100
  2. Technology Overview.....II-37 $500  
   Definition of Gene Amplification.....II-3
Target vs. Signal Amplification.....II-3
Available Types of Gene Amplification Technologies.....II-3
Polymerase Chain Reaction.....II-3
1$100
   Reagents and Equipment required for PCR.....II-4
Reaction Steps.....II-4
Denaturation.....II-4
Annealing.....II-4
Extension.....II-4
1$100
   Detection of Amplified Product/DNA.....II-5
(Q&Q) PCR.....II-5
Reverse Transcriptase PCR (RT-PCR).....II-5
1$100
   Alternative Technologies to PCR.....II-6
OmniPlex.....II-6
Strand Displacement Amplification.....II-6
1$100
   Ligase Chain Reaction.....II-7
LCR Involves a Cyclic Two-Step Reaction.....II-7
Gene Amplification Technology (GAT).....II-7
Hybrid Capture.....II-7
Isothermal DNA Amplification Techniques.....II-7
Rolling circle Amplification in Diagnostics.....II-7
1$100
   Ican Isothermal Gene Amplification Technology.....II-8
Other Amplification Technologies.....II-8
Signal Amplification Technology.....II-8
Transcription Mediated Amplification.....II-8
1$100
   DNA cleavage-based signal amplification.....II-9
Ramification Amplification Method.....II-9
1$100
  3. End Use Market Analysis.....II-103 $300  
   Medical and Diagnostics.....II-10
Role of Amplification Technology in Diagnostics of Infectious Diseases.....II-10
Diagnosis of Infectious Diseases by PCR.....II-10
1$100
   Detection of Antimicrobial Resistance.....II-11
PCR Based Nucleic Acid Amplification for Detection of Antimicrobial Agents.....II-11
Nucleic Acid Amplification Testing (NAT).....II-11
1$100
   Nucleic Acid Amplification Methods II-11 DNA Amplification Technology in the Diagnosis
  of Infectious Diseases.....II-12
Forensic and Paternity.....II-12
Food Safety.....II-12
1$100
  4. Product Innovations/Launches.....II-136 $400  
   Bio-Rad Launches New CFX96 PCR Detection System.....II-13
Roche Introduces Genome Sequencer FLX System.....II-13
QIAGEN Launches TopTaq DNA Polymerase.....II-13
Applied Biosystems Introduces TaqMan Array Human MicroRNA Panel.....II-13
1$100
   Spartan Introduces Spartan DX.....II-14
Applied Biosystems Launches Forensic Tools.....II-14
1$100
   Applied Biosystems Introduces StepOne Real-Time PCR System.....II-15
Sigma-Aldrich Unveils GenomePlex Tissue Whole Genome Amplification Kit.....II-15
QIAGEN Rolls Out Wide RNAi and SYBR® Green-based RT- PCR.....II-15
Applied Biosystems Launches 7500 Fast Real-Time PCR System.....II-15
1$100
   Applied Biosystems Launches 9800 Fast PCR System.....II-16
7900HT Fast Real-Time PCR System from Applied Biosystems.....II-16
Enzo Life Sciences Introduces New Advanced Amplification Technology.....II-16
Applied Biosystems Unveils AmpFSTR® Yfiler™ PCR Amplification Kit.....II-16
1$100
   Amersham Launches GenomiPhi.....II-17
Rubicon Genomics Launches GenomePlex WGA.....II-17
Agilent Introduces Amplification Kit.....II-17
Linden Introduces Snapshot mRNA.....II-17
1$100
   Rubicon Launches OmniPlex™.....II-18
1$100
  5. Recent Industry Activity.....II-196 $600  
   Hologic Acquires Third Wave Technologies.....II-19
BIOTECON Acquires Roche's Technology License.....II-19
QIAGEN Signs a Global Licensing Agreement with BioHelix.....II-19
BioTrove and Gene Express Receive NIH Grant for Innovative Bio-experimentation.....II-19
1$100
   SuperArray Bioscience Inks License Agreement with Applied Biosystems.....II-20
Merck Capital Takes Over Minority Interest in High Throughput Genomics.....II-20
NuGEN Enters into a Service Agreement with ExonHit.....II-20
1$100
   Qiagen Enters into License Agreements with Roche and Ortho-Clinical.....II-21
Agilent Takes Over Stratagene.....II-21
Eiken Chemical Inks Licensing Agreement with Meridian Bioscience.....II-21
1$100
   Sigma-Aldrich Acquires JRH.....II-22
Sigma-Aldrich Snaps Up Proligo.....II-22
Beckman to Acquire Agencourt.....II-22
Roche Diagnostics and Applera Corporation Expand PCR Licensing Program.....II-22
Mount and Hamilton Receive Patent.....II-22
Invitrogen Bags License from Applied Biosystems.....II-22
OriGene to Access TrueClone.....II-22
1$100
   Orchid BioSciences to Turn into Orchid Cellmark.....II-23
QIAGEN Purchases Assets of Molecular Staging.....II-23
Cepheid, Applied Biosystems and Celera Diagnostics Sign Patent License
  Agreement.....II-23
Abbott Enters into Agreement with BioGenex.....II-23
Roche Inks Licensing Agreement with Incyte Corp.....II-23
1$100
   Rubicon Genomics Signs Licensing Agreement with Sigma-Aldrich.....II-24
BioMérieux Teams-up with Cepheid.....II-24
Molecular Staging Collaborates with Eli Lilly.....II-24
Pacific Biometrics Inc. Receives Gene Amplification Patent .....II-24
Rubicon Introduces Service for Genome Amplification .....II-24
Takara Obtains Patent for New Amplification Method.....II-24
1$100
  6. Focus on Select Global Players.....II-253 $300  
   Abbott Laboratories (US).....II-25
Applied Biosystems (US).....II-25
Becton, Dickinson and Company (US).....II-25
1$100
   bioMérieux (France).....II-26
Bio-Rad Laboratories (US).....II-26
Cepheid (US).....II-26
QIAGEN N.V (The Netherlands).....II-26
1$100
   Roche Diagnostics (Switzerland).....II-27
Rubicon Genomics (US).....II-27
Takara Bio, Inc......II-27
1$100
  7. Global Market Perspective.....II-28   
   Table 1: World Recent Past, Current & Future Market Analysis for Gene Amplification Technologies by Geographic Region – US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-281$300
   Table 2: World Long-term Projections for Gene Amplification Technologies by Geographic Region – US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-291$300
   Table 3: World 10-Year Perspective for Gene Amplification Technologies by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-301$300
   Table 4: World Recent Past, Current & Future Market Analysis for Polymerase Chain Reaction (PCR) by Geographic Region – US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-311$300
   Table 5: World Long-term Projections for Polymerase Chain Reaction (PCR) by Geographic Region – US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-321$300
   Table 6: World 10-Year Perspective for Polymerase Chain Reaction (PCR) by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-331$300
   Table 7: World Recent Past, Current & Future Market Analysis for Other Gene Amplification Technologies by Geographic Region – US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-341$300
   Table 8: World Long-term Projections for Other Gene Amplification Technologies by Geographic Region – US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-351$300
   Table 9: World 10-Year Perspective for Other Gene Amplification Technologies by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-361$300
III. MARKET38$1950
  1. The United States.....III-111 $675  
   A. Market Analysis.....III-1
Product Launches.....III-1
3$225
   Strategic Corporate Developments.....III-44$300
   Key Players.....III-8
Abbott Laboratories.....III-8
1$75
   Applied Biosystems.....III-9
Bio-Rad Laboratories.....III-9
Cepheid.....III-9
Rubicon Genomics.....III-9
1$75
   B. Market Analytics.....III-10
Table 10: US Recent Past, Current & Future Analysis for Gene Amplification Technologies by Segment – Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-10
1$150
   Table 11: US Long-term Projections for Gene Amplification Technologies by Segment – Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-11

Table 12: US 10-Year Perspective for Gene Amplification Technologies by Segment – Percentage Breakdown of Dollar Sales for Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets for 2003, 2008 & 2012.....III-11
1$150
  2. Canada.....III-123 $225  
   A. Market Analysis.....III-12
Strategic Corporate Developments.....III-12
1$75
   B. Market Analytics.....III-13
Table 13: Canadian Recent Past, Current & Future Analysis for Gene Amplification Technologies by Segment – Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-13
1$150
   Table 14: Canadian Long-term Projections for Gene Amplification Technologies by Segment – Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-14

Table 15: Canadian 10-Year Perspective for Gene Amplification Technologies by Segment – Percentage Breakdown of Dollar Sales for Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets for 2003, 2008 & 2012.....III-14
1$150
  3. Japan.....III-153 $225  
   A. Market Analysis.....III-15
Key Player.....III-15
Takara Bio, Inc......III-15
1$75
   B. Market Analytics.....III-16
Table 16: Japanese Recent Past, Current & Future Analysis for Gene Amplification Technologies by Segment – Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-16
1$150
   Table 17: Japanese Long-term Projections for Gene Amplification Technologies by Segment – Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-17

Table 18: Japanese 10-Year Perspective for Gene Amplification Technologies by Segment – Percentage Breakdown of Dollar Sales for Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets for 2003, 2008 & 2012.....III-17
1$150
  4. Europe.....III-184 $475  
   Market Analysis.....III-18
Table 19: European Recent Past, Current & Future Analysis for Gene Amplification Technologies by Geographic Region – France, Germany, UK, Italy, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-18
1$150
   Table 20: European Long-term Projections for Gene Amplification Technologies by Geographic Region – France, Germany, UK, Italy, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-19

Table 21: European Recent Past, Current & Future Analysis for Gene Amplification Technologies by Segment – Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-19
1$150
   Table 22: European Long-term Projections for Gene Amplification Technologies by Segment – Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-201$150
   Table 23: European 10-Year Perspective for Gene Amplification Technologies by Geographic Region – Percentage Breakdown of Dollar Sales for France, Germany, UK, Italy, & Rest of Europe Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-21

Table 24: European 10-Year Perspective for Gene Amplification Technologies by Segment – Percentage Breakdown of Dollar Sales for Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets for 2003, 2008 & 2012.....III-21
1$150
  4a. France.....III-223 $225  
   A. Market Analysis.....III-22
Key Player.....III-22
bioMérieux.....III-22
1$75
   B. Market Analytics.....III-23
Table 25: French Recent Past, Current & Future Analysis for Gene Amplification Technologies by Segment – Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-23
1$150
   Table 26: French Long-term Projections for Gene Amplification Technologies by Segment – Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-24

Table 27: French 10-Year Perspective for Gene Amplification Technologies by Segment – Percentage Breakdown of Dollar Sales for Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets for 2003, 2008 & 2012.....III-24
1$150
  4b. Germany.....III-252 $200  
   Market Analysis.....III-25
Table 28: German Recent Past, Current & Future Analysis for Gene Amplification Technologies by Segment – Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-25
1$150
   Table 29: German Long-term Projections for Gene Amplification Technologies by Segment – Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-26

Table 30: German 10-Year Perspective for Gene Amplification Technologies by Segment – Percentage Breakdown of Dollar Sales for Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets for 2003, 2008 & 2012.....III-26
1$150
  4c. United Kingdom.....III-272 $200  
   Market Analysis.....III-27
Table 31: UK Recent Past, Current & Future Analysis for Gene Amplification Technologies by Segment – Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-27
1$150
   Table 32: UK Long-term Projections for Gene Amplification Technologies by Segment – Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-28

Table 33: UK 10-Year Perspective for Gene Amplification Technologies by Segment – Percentage Breakdown of Dollar Sales for Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets for 2003, 2008 & 2012.....III-28
1$150
  4d. Italy.....III-292 $200  
   Market Analysis.....III-29
Table 34: Italian Recent Past, Current & Future Analysis for Gene Amplification Technologies by Segment – Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-29
1$150
   Table 35: Italian Long-term Projections for Gene Amplification Technologies by Segment – Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-30

Table 36: Italian 10-Year Perspective for Gene Amplification Technologies by Segment – Percentage Breakdown of Dollar Sales for Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets for 2003, 2008 & 2012.....III-30
1$150
  4e. Rest of Europe.....III-315 $375  
   A. Market Analysis.....III-31
Product Launches.....III-31
1$75
   Strategic Corporate Development.....III-321$75
   Key Players.....III-33
Roche Diagnostics (Switzerland).....III-33
QIAGEN N.V (Netherlands).....III-33
1$75
   B. Market Analytics.....III-34
Table 37: Rest of Europe Market for Gene Amplification Technologies - Recent Past, Current & Future Market Analysis by Segment for Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-34
1$150
   Table 38: Rest of Europe Long-term Projections for Gene Amplification Technologies by Segment – Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-35

Table 39: Rest of Europe 10-Year Perspective for Gene Amplification Technologies by Segment – Percentage Breakdown of Dollar Sales for Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets for 2003, 2008 & 2012.....III-35
1$150
  5. Rest of World.....III-363 $375  
   A. Market Analysis.....III-36
Product Launch.....III-36
Strategic Corporate Developments.....III-36
1$75
   B. Market Analytics.....III-37
Table 40: Rest of World Market for Gene Amplification Technologies - Recent Past, Current & Future Market Analysis by Segment for Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-37
1$150
   Table 41: Rest of World (*) Long-term Projections for Gene Amplification Technologies by Segment – Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-38

Table 42: Rest of World 10-Year Perspective for Gene Amplification Technologies by Segment – Percentage Breakdown of Dollar Sales for Polymerase Chain Reaction (PCR) and Other Gene Amplification Markets for 2003, 2008 & 2012.....III-38
1$150
IV. COMPETITIVE LANDSCAPE 197$995
  
Total Companies Profiled: 93 (including Divisions/Subsidiaries - 106)

Region/Country                 Players


The United States                 62   
Canada                             4
Japan                              4
Europe                            34
     France                        3
     Germany                       5
     The United Kingdom           15
     Italy                         1
     Spain                         2
     Rest of Europe                8
Asia-Pacific (Excluding Japan)     2
Click here to request a full table of contents and more details on this project.		  
 
 
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

© Copyrights 2010, Global Industry Analysts, Inc., USA.